Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03111901 |
| Title | Low-dose Interleukin-2 and Pembrolizumab in Melanoma and Renal Cell Cancer |
| Acronym | UVA-AM-002 |
| Recruitment | Withdrawn |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | William Grosh, MD |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Virginia Cancer Center | Charlottesville | Virginia | 22908 | United States | Details |